An Xu
- Topics
- Inflammatory Bowel Disease (4 papers)Cancer-related molecular mechanisms research (2 papers)Synthesis of heterocyclic compounds (1 paper)
- Cited by
- Cancer ResearchImmunologyOncology
In The Last Decade
An Xu
13 papers receiving 304 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 162
- Cancer Research 140
- Oncology 68
- Immunology 68
- Epidemiology 42
Countries citing papers authored by An Xu
This map shows the geographic impact of An Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Xu more than expected).
Fields of papers citing papers by An Xu
This network shows the impact of papers produced by An Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Xu. The network helps show where An Xu may publish in the future.
Co-authorship network of co-authors of An Xu
This figure shows the co-authorship network connecting the top 25 collaborators of An Xu. A scholar is included among the top collaborators of An Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Xu. An Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Heptaphylline suppresses the proliferation and migration of human bladder cancer cells via induction of intrinsic apoptosis, autophagy and inhibition of β-catenin signalling pathway. | 1 |
| 2 | 1 | |
| 3 | 21 | |
| 4 | 2 | |
| 5 | 14 | |
| 6 | 20 | |
| 7 | 20 | |
| 8 | 55 | |
| 9 | 5 | |
| 10 | 30 | |
| 11 | 11 | |
| 12 | 84 | |
| 13 | 40 |
About An Xu
An Xu is a scholar working on Cancer Research, Physiology and Immunology, having authored 13 papers that have together received 304 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (4 papers), Cancer-related molecular mechanisms research (2 papers) and Synthesis of heterocyclic compounds (1 paper). The work is most often cited by research in Cancer Research (140 citations), Immunology (68 citations) and Oncology (68 citations). An Xu has collaborated with scholars based in China and Rwanda. Frequent co-authors include Zhi Hua Ran, Jun Shen, Yu Qiao, Di Zhao, Mei Huang, Qing Zheng, Jin Lu Tong, Xi Xu, Ming Zhu and Qi Xu. Their work appears in journals such as Inflammatory Bowel Diseases, Cancer Science and Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.